| BSX |
Report |
WATCHMAN Revenue (Q2 2026) |
MISS |
pred ~$508M vs. cons $514M |
MEDIUM |
| BSX |
Report |
EP Revenue (Q2 2026) |
MISS |
pred ~$895M vs. cons $906M |
MEDIUM |
| BSX |
Report |
Adj. EPS (Q2 2026) |
BEAT |
pred ~$0.84 vs. cons $0.827 |
MEDIUM |
| BSX |
Guide |
FY 2026 Organic Growth (FY) |
UNCHANGED |
guide reaffirm 6.5-8% vs. cons 6.3% |
MEDIUM |
| BSX |
Guide |
FY 2026 Adj. EPS (FY) |
UNCHANGED |
guide reaffirm $3.34-$3.41 vs. cons $3.354 |
MEDIUM |
| BSX |
Guide |
WATCHMAN Qualitative (Q3 2026) |
LOWER |
guide flat dollar Q3 vs. cons ~$514M (above flat) |
HIGH |
| BSX |
Guide |
Restructuring Savings (FY 2026+) |
BETTER |
guide $500M gross savings 2026-2029; new positive narrative vs. no prior guide |
LOW |
| BSX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+3.5% |
— |
MEDIUM |
| BSX |
Return |
5-day cumulative residual |
-1.5% (FADE) |
FADE - revenue misses on WATCHMAN/EP drive modest sell-side cuts; restructuring narrative limits damage but does not reverse the fade |
MEDIUM |